{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:28:17Z","timestamp":1793899697392,"version":"4.8.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00415-026-14190-5","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:28:10Z","timestamp":1791304090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex-related phenotypic differences in myotonic dystrophy types 1 and 2: a nationwide registry study from Serbia"],"prefix":"10.1007","volume":"273","author":[{"given":"Ana","family":"Azanjac Arsic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Andrejic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanja","family":"Viric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilija","family":"Gunjic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Sreckovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Rajic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zita","family":"Jovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Bozovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Djordjevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Basta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-556X","authenticated-orcid":false,"given":"Stojan","family":"Peric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"10","key":"14190_CR1","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","volume":"11","author":"B Udd","year":"2012","unstructured":"Udd B, Krahe R (2012) The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 11(10):891\u2013905. https:\/\/doi.org\/10.1016\/S1474-4422(12)70204-1","journal-title":"Lancet Neurol"},{"issue":"1","key":"14190_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010354","volume":"23","author":"S Peric","year":"2021","unstructured":"Peric S, Pesovic J, Savic-Pavicevic D, Rakocevic Stojanovic V, Meola G (2021) Molecular and clinical implications of variant repeats in myotonic dystrophy type 1. IJMS 23(1):354. https:\/\/doi.org\/10.3390\/ijms23010354","journal-title":"IJMS"},{"key":"14190_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123659","volume":"373","author":"D Chakraborty","year":"2025","unstructured":"Chakraborty D, Borthakur S, Sarkar R, Singh MD (2025) Gender disparities in myotonic dystrophy 1. Life Sci 373:123659. https:\/\/doi.org\/10.1016\/j.lfs.2025.123659","journal-title":"Life Sci"},{"issue":"5531","key":"14190_CR4","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1062125","volume":"293","author":"CL Liquori","year":"2001","unstructured":"Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL et al (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293(5531):864\u2013867. https:\/\/doi.org\/10.1126\/science.1062125","journal-title":"Science"},{"issue":"4","key":"14190_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1212\/01.WNL.0000054481.84978.F9","volume":"60","author":"JW Day","year":"2003","unstructured":"Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W et al (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60(4):657\u2013664. https:\/\/doi.org\/10.1212\/01.WNL.0000054481.84978.F9","journal-title":"Neurology"},{"issue":"12","key":"14190_CR6","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1007\/s00415-017-8653-2","volume":"264","author":"F Montagnese","year":"2017","unstructured":"Montagnese F, Mondello S, Wenninger S, Kress W, Schoser B (2017) Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2. J Neurol 264(12):2472\u20132480. https:\/\/doi.org\/10.1007\/s00415-017-8653-2","journal-title":"J Neurol"},{"issue":"9","key":"14190_CR7","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s00415-017-8574-0","volume":"264","author":"S Peric","year":"2017","unstructured":"Peric S, Maksimovic R, Banko B, Durdic M, Bjelica B, Bozovic I et al (2017) Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies. J Neurol 264(9):1899\u20131908. https:\/\/doi.org\/10.1007\/s00415-017-8574-0","journal-title":"J Neurol"},{"issue":"25","key":"14190_CR8","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1056\/NEJMoa062800","volume":"358","author":"WJ Groh","year":"2008","unstructured":"Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, Marashdeh MM, Zipes DP, Pascuzzi RM (2008) Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 358(25):2688\u20132697. https:\/\/doi.org\/10.1056\/NEJMoa062800","journal-title":"N Engl J Med"},{"issue":"2","key":"14190_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148264","volume":"11","author":"C Dogan","year":"2016","unstructured":"Dogan C, De Antonio M, Hamroun D, Varet H, Fabbro M, Rougier F et al (2016) Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study. PLoS ONE 11(2):e0148264. https:\/\/doi.org\/10.1371\/journal.pone.0148264","journal-title":"PLoS ONE"},{"issue":"1","key":"14190_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1088-3","volume":"14","author":"M De Antonio","year":"2019","unstructured":"De Antonio M, Dogan C, Daidj F, Eymard B, Puymirat J, Mathieu J et al (2019) The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care. Orphanet J Rare Dis 14(1):122. https:\/\/doi.org\/10.1186\/s13023-019-1088-3","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"14190_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16513","volume":"31","author":"Z Calic","year":"2024","unstructured":"Calic Z, Peric S, Vujnic M, Bjelica B, Bozovic I, Rakocevic\u2010Stojanovic V et al (2024) Video head impulse gain is impaired in myotonic dystrophy types 1 and 2. Eur J Neurol 31(12):e16513. https:\/\/doi.org\/10.1111\/ene.16513","journal-title":"Eur J Neurol"},{"issue":"6","key":"14190_CR12","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1177\/22143602241290353","volume":"11","author":"S Peric","year":"2024","unstructured":"Peric S, Ivanovic V, Ashley EJ, Esparis B, Campbell C, Wenninger S et al (2024) International collaboration to improve knowledge on myotonic dystrophy type 2. J Neuromuscul Dis 11(6):1229\u20131237. https:\/\/doi.org\/10.1177\/22143602241290353","journal-title":"J Neuromuscul Dis"},{"key":"14190_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.658532","volume":"12","author":"L Hartog","year":"2021","unstructured":"Hartog L, Zhao J, Reynolds J, Brokamp G, Vilson F, Arnold WD et al (2021) Factors influencing the severity and progression of respiratory muscle dysfunction in myotonic dystrophy type 1. Front Neurol 12:658532. https:\/\/doi.org\/10.3389\/fneur.2021.658532","journal-title":"Front Neurol"},{"issue":"4","key":"14190_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1179\/1743132812Y.0000000144","volume":"35","author":"S Peric","year":"2013","unstructured":"Peric S, Stojanovic VR, Nikolic A, Kacar A, Basta I, Pavlovic S et al (2013) Peripheral neuropathy in patients with myotonic dystrophy type 1. Neurol Res 35(4):331\u2013335. https:\/\/doi.org\/10.1179\/1743132812Y.0000000144","journal-title":"Neurol Res"},{"issue":"3","key":"14190_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pjnns.2015.04.008","volume":"49","author":"M Nojszewska","year":"2015","unstructured":"Nojszewska M, \u0141usakowska A, Szmidt-Salkowska E, Gawe\u0142 M, Lipowska M, Su\u0142ek A et al (2015) Peripheral nerve involvement in myotonic dystrophy type 2 \u2013 similar or different than in myotonic dystrophy type 1? Neurol Neurochir Pol 49(3):164\u2013170. https:\/\/doi.org\/10.1016\/j.pjnns.2015.04.008","journal-title":"Neurol Neurochir Pol"},{"issue":"8","key":"14190_CR16","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/NEN.0b013e3182260939","volume":"70","author":"PA Panaite","year":"2011","unstructured":"Panaite PA, Kielar M, Kraftsik R, Gourdon G, Kuntzer T, Barakat-Walter I (2011) Peripheral neuropathy is linked to a severe form of myotonic dystrophy in transgenic mice. J Neuropathol Exp Neurol 70(8):678\u2013685. https:\/\/doi.org\/10.1097\/NEN.0b013e3182260939","journal-title":"J Neuropathol Exp Neurol"},{"key":"14190_CR17","first-page":"106","volume":"2","author":"S Peric","year":"2013","unstructured":"Peric S, Nisic T, Milicev M, Basta I, Marjanovic I, Peric M et al (2013) Hypogonadism and erectile dysfunction in myotonic dystrophy type 1. Acta Myol 2:106\u20139 (PubMed PMID: 24399868; PubMed Central PMCID: PMC3866901)","journal-title":"Acta Myol"},{"issue":"9","key":"14190_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137620","volume":"10","author":"L Michel","year":"2015","unstructured":"Michel L, Huguet-Lachon A, Gourdon G (2015) Sense and antisense DMPK RNA foci accumulate in DM1 tissues during development. PLoS ONE 10(9):e0137620. https:\/\/doi.org\/10.1371\/journal.pone.0137620","journal-title":"PLoS ONE"},{"key":"14190_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-981-13-0508-5_10","volume-title":"Myotonic dystrophy","author":"H Takada","year":"2018","unstructured":"Takada H (2018) Lipid metabolism in myotonic dystrophy. In: Takahashi MP, Matsumura T (eds) Myotonic dystrophy. Springer Singapore, Singapore, pp 161\u2013170. https:\/\/doi.org\/10.1007\/978-981-13-0508-5_10"},{"issue":"4","key":"14190_CR20","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/ene.14665","volume":"28","author":"M Garibaldi","year":"2021","unstructured":"Garibaldi M, Lauletta A, Bucci E, Fionda L, Vanoli F, Leonardi L et al (2021) Gender effect on cardiac involvement in myotonic dystrophy type 1. Eur J Neurol 28(4):1366\u20131374. https:\/\/doi.org\/10.1111\/ene.14665","journal-title":"Eur J Neurol"},{"issue":"2","key":"14190_CR21","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.ijcard.2012.11.076","volume":"168","author":"VA Sansone","year":"2013","unstructured":"Sansone VA, Brigonzi E, Schoser B, Villani S, Gaeta M, De Ambroggi G et al (2013) The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes. Int J Cardiol 168(2):1147\u20131153. https:\/\/doi.org\/10.1016\/j.ijcard.2012.11.076","journal-title":"Int J Cardiol"},{"issue":"s2","key":"14190_CR22","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.3233\/JND-150088","volume":"2","author":"G Meola","year":"2015","unstructured":"Meola G, Cardani R (2015) Myotonic dystrophy type 2: an update on clinical aspects, genetic and pathomolecular mechanism. JND 2(s2):S59-71. https:\/\/doi.org\/10.3233\/JND-150088","journal-title":"JND"},{"issue":"4","key":"14190_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JND-180328","volume":"5","author":"I Bozovic","year":"2018","unstructured":"Bozovic I, Peric S, Pesovic J, Bjelica B, Brkusanin M, Basta I et al (2018) Myotonic dystrophy type 2 \u2013 data from the Serbian registry. J Neuromuscul Dis 5(4):461\u2013469. https:\/\/doi.org\/10.3233\/JND-180328","journal-title":"J Neuromuscul Dis"},{"issue":"11","key":"14190_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/genes15111409","volume":"15","author":"A Luglio","year":"2024","unstructured":"Luglio A, Maggi E, Riviello FN, Conforti A, Sorrentino U, Zuccarello D (2024) Hereditary neuromuscular disorders in reproductive medicine. Genes (Basel) 15(11):1409. https:\/\/doi.org\/10.3390\/genes15111409","journal-title":"Genes (Basel)"},{"issue":"2","key":"14190_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3109\/02713683.2014.898774","volume":"40","author":"M Zetterberg","year":"2015","unstructured":"Zetterberg M, Celojevic D (2015) Gender and cataract \u2013 the role of estrogen. Curr Eye Res 40(2):176\u2013190. https:\/\/doi.org\/10.3109\/02713683.2014.898774","journal-title":"Curr Eye Res"},{"issue":"4","key":"14190_CR26","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.5301\/ejo.5000565","volume":"25","author":"NC Voermans","year":"2015","unstructured":"Voermans NC, Erasmus CE, Ockeloen CW, Van Engelen BG, Eggink CA (2015) Primary cataract as a key to recognition of myotonic dystrophy type 1. Eur J Ophthalmol 25(4):e46\u2013e49. https:\/\/doi.org\/10.5301\/ejo.5000565","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"14190_CR27","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/archneurol.2011.191","volume":"68","author":"C Heatwole","year":"2011","unstructured":"Heatwole C, Johnson N, Goldberg B, Martens W, Moxley R (2011) Laboratory abnormalities in patients with myotonic dystrophy type 2. Arch Neurol 68(9):1180. https:\/\/doi.org\/10.1001\/archneurol.2011.191","journal-title":"Arch Neurol"},{"issue":"5","key":"14190_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/ane.12635","volume":"135","author":"L Leonardis","year":"2017","unstructured":"Leonardis L (2017) Peripheral neuropathy in patients with myotonic dystrophy type 2. Acta Neurol Scand 135(5):568\u2013575. https:\/\/doi.org\/10.1111\/ane.12635","journal-title":"Acta Neurol Scand"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14190-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:04:23Z","timestamp":1793898263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14190-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["14190"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14190-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"24 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflict of interest to report.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The establishment of the Serbian registry for rare neuromuscular diseases, including myotonic dystrophies, was approved by the Ethics Committee of the Faculty of Medicine, University of Belgrade (decision 29\/XI-7 from November 20, 2013) and by the Ethics Committee of the University Clinical Center of Serbia (decision 18\/10 from February 23, 2026). This additional approval was required due to changes in the applicable regulations in Serbia. Both approvals allow anonymous group data of patients to be published in the form of scientific publications without additional approval from the Ethics Committee and without signing of additional informed consent by patients.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Signed patient informed consent was waived as the study was based on anonymized data from a national disease registry, the establishment of which was approved by the relevant ethics committees with provisions for the publication of anonymized group data without additional informed consent.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"645"}}